KR20230003495A - 감염증에서 혈류역학을 조절하기 위한 방법 및 수단 - Google Patents

감염증에서 혈류역학을 조절하기 위한 방법 및 수단 Download PDF

Info

Publication number
KR20230003495A
KR20230003495A KR1020227038443A KR20227038443A KR20230003495A KR 20230003495 A KR20230003495 A KR 20230003495A KR 1020227038443 A KR1020227038443 A KR 1020227038443A KR 20227038443 A KR20227038443 A KR 20227038443A KR 20230003495 A KR20230003495 A KR 20230003495A
Authority
KR
South Korea
Prior art keywords
peptide
aqgv
leu
patients
prt
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
KR1020227038443A
Other languages
English (en)
Korean (ko)
Inventor
겔트 웬스부르트
에릭 클라센
요한 레네스
Original Assignee
바이오템프트, 비.브이.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 바이오템프트, 비.브이. filed Critical 바이오템프트, 비.브이.
Publication of KR20230003495A publication Critical patent/KR20230003495A/ko
Pending legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/10—Peptides having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/07—Tetrapeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Virology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Molecular Biology (AREA)
  • Pulmonology (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
KR1020227038443A 2020-04-06 2021-04-06 감염증에서 혈류역학을 조절하기 위한 방법 및 수단 Pending KR20230003495A (ko)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US202063005999P 2020-04-06 2020-04-06
US63/005,999 2020-04-06
US202063045737P 2020-06-29 2020-06-29
US63/045,737 2020-06-29
US202063085771P 2020-09-30 2020-09-30
US63/085,771 2020-09-30
PCT/NL2021/050223 WO2021206547A1 (en) 2020-04-06 2021-04-06 Methods and means for modifying hemodynamics in infections

Publications (1)

Publication Number Publication Date
KR20230003495A true KR20230003495A (ko) 2023-01-06

Family

ID=75581581

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020227038443A Pending KR20230003495A (ko) 2020-04-06 2021-04-06 감염증에서 혈류역학을 조절하기 위한 방법 및 수단

Country Status (9)

Country Link
US (1) US20230241155A1 (https=)
EP (1) EP4132556A1 (https=)
JP (2) JP2023521744A (https=)
KR (1) KR20230003495A (https=)
AU (1) AU2021252821A1 (https=)
CA (1) CA3174852A1 (https=)
CO (1) CO2022015018A2 (https=)
MX (1) MX2022012506A (https=)
WO (1) WO2021206547A1 (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4021481A1 (en) * 2019-08-30 2022-07-06 Biotempt B.V. Q-er peptide
AU2021354766A1 (en) * 2020-09-30 2023-05-11 Biotempt B.V. Autophagy-inhibiting peptide and organic acid salt thereof addressing issues of vascular permeability
WO2025191033A1 (en) 2024-03-13 2025-09-18 Biotempt B.V. Per-operative treatment of post-operative complications (poc)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ542791A (en) * 2003-04-08 2008-04-30 Biotempt Bv Compositions for mucosal and oral administration comprising HCG fragments
EP4021481A1 (en) * 2019-08-30 2022-07-06 Biotempt B.V. Q-er peptide
CA3152346A1 (en) * 2019-09-30 2021-04-08 Roelof Peter Pickkers Methods of treatment for modifying hemodynamics

Also Published As

Publication number Publication date
JP2026027378A (ja) 2026-02-18
MX2022012506A (es) 2023-01-16
EP4132556A1 (en) 2023-02-15
WO2021206547A1 (en) 2021-10-14
JP2023521744A (ja) 2023-05-25
CA3174852A1 (en) 2021-10-14
US20230241155A1 (en) 2023-08-03
CO2022015018A2 (es) 2022-10-31
AU2021252821A1 (en) 2022-11-24

Similar Documents

Publication Publication Date Title
JP2026027378A (ja) 感染症における血行動態を変更する為の方法及び手段
CN104427993B (zh) 用于治疗由缺氧和低气压造成的肺型高山病的药物组合物
AU2020337111A1 (en) Q-ER peptide
JP2025134782A (ja) 医薬製剤およびストック溶液
EP1357930B1 (en) Histidine-rich glycoprotein (hrgp) for inhibiting angiogenesis
KR20220166809A (ko) 급성 호흡곤란 증후군 및 바이러스 감염 치료를 위한 cxcr4 억제제
KR20080017021A (ko) 중증 박테리아 감염을 치료하기 위한 ｔｆｐｉ의 용도
US20220193204A1 (en) Uses of a2 domain of von willebrand factor
US10550172B2 (en) Serpin reactive center loop peptides and methods of use
KR20230079126A (ko) 혈관 투과성 문제를 해결하는 자가포식-저해성 펩타이드 및 이의 유기산 염
CN106413744A (zh) 用于在出血性疾病治疗中改善止血的人凝血酶原和活化的因子x的组合物
US20210369665A1 (en) Methods of treating viral infection using protease inhibitors
US20240325496A1 (en) Cxc chemokine agonists and antagonists in covid-19 disease and diagnostic assays
US20210052701A1 (en) Methods of Treating Vascular Leakage Using CXCL12 Peptides
WO2021189038A1 (en) Ang 1-7 as a therapeutic for coronavirus
EP4331571A1 (en) Formulations of ace2-igm fusion proteins
ES2986586T3 (es) Fármaco para el tratamiento y/o la mejora de septicemia asociada a anomalía de la coagulación
WO2021232066A1 (en) Vimentin and fragments or derivatives thereof for coronavirus treatment and prevention
CN108553636A (zh) 蛋白c在制备防治肺动脉高压病药物中的应用
Hatip-Al-Khatib SARS-CoV-2 Molecular Peculiarities are Armaments Employed by the Virus but could be Potential Targets for Drugs
HK1196289A1 (zh) 用於败血症的治疗和/或改善的药物
HK1196289B (en) Medicine for treatment and/or improvement of sepsis

Legal Events

Date Code Title Description
PA0105 International application

St.27 status event code: A-0-1-A10-A15-nap-PA0105

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

PG1501 Laying open of application

St.27 status event code: A-1-1-Q10-Q12-nap-PG1501

A201 Request for examination
PA0201 Request for examination

St.27 status event code: A-1-2-D10-D11-exm-PA0201

D21 Rejection of application intended

Free format text: ST27 STATUS EVENT CODE: A-1-2-D10-D21-EXM-PE0902 (AS PROVIDED BY THE NATIONAL OFFICE)

PE0902 Notice of grounds for rejection

St.27 status event code: A-1-2-D10-D21-exm-PE0902